As I understand it, once we enroll patient #50, the 2 week and 4 week clocks begin. The primary endpoint in the ph2b/3 is Mortality at 28 days, with a secondary endpoint at `14 days.

My guess is that they structured it this way so they can take a peek after 2 weeks.

So, if it takes 2 weeks from today to enroll patient #50, we are 4 weeks away from the FDA reviewing the secondary endpoint.

I wish it was sooner.